Hyponatremia and hypercalcemia: a study of a large cohort of patients with lung cancer

No Thumbnail Available
Files
35140-PB1-3173-R2.pdf(257.07 KB)
Published Version
Date
2019-10-11
Authors
Chan, Vanessa W. Q.
Henry, Michael T.
Kennedy, Marcus P.
Journal Title
Journal ISSN
Volume Title
Publisher
AME Publishing Company
Published Version
Research Projects
Organizational Units
Journal Issue
Abstract
Background: Hyponatremia and hypercalcemia are reported to be associated with poorer prognosis in lung cancer. Our study assessed the incidence of hyponatremia and hypercalcemia in a recent large cohort of patients diagnosed with lung cancer in an academic institution and correlated incidence with patient and tumour parameters. Methods: All patients presented at our regional lung cancer multidisciplinary team meeting between January 2011 and December 2016 were included. The incidence of hyponatremia (serum sodium ≤135 mEq/L) and hypercalcemia (serum calcium >2.62 mmol/L), including severity (mild, moderate or severe) was evaluated and stratified by tumour subtype and stage, and correlated with patient parameters. Results: A total of 624 patients (mean age, 67.4 years; 59.3% male) diagnosed with tissue-proven lung cancer were included. Hyponatremia and hypercalcemia were present in 31.6% (n=197) and 7.1% (n=44) at time of diagnosis. Hyponatremia occurred most commonly in patients with small cell lung carcinoma (SCLC) (n=42; 41.2%; P=0.001). Hypercalcemia occurred most commonly in patients with non-small cell lung carcinoma (NSCLC) squamous subtype (n=27; 12.2%; P=0.003). The incidence of hyponatremia and hypercalcemia were significantly higher in the advanced stages (P<0.041), except in SCLC where no difference in hypercalcemia incidence across the stages was observed (P=0.573). The Eastern Cooperative Oncology Group Performance Status (ECOG-PS) score was positively correlated with severity of hyponatremia at the early stage of NSCLC (Spearman correlation coefficient =0.325; P=0.003). Conclusions: Hyponatremia is a common association in lung cancer, especially in SCLC. Hypercalcemia is an uncommon but significant association in the NSCLC squamous subtype. Hyponatremia might contribute to poorer ECOG-PS scores at the early stage of NSCLC.
Description
Keywords
Epidemiology , Hyponatremia , Hypercalcemia , Small cell lung cancer , Non-small cell lung cancer
Citation
Chan, V. W. Q., Henry, M. T. and Kennedy, M. P. (2019) ‘Hyponatremia and hypercalcemia: a study of a large cohort of patients with lung cancer’, Translational Cancer Research, 9(1), pp. 222-230. doi: 10.21037/tcr.2019.12.72
Copyright
© 2019, Translational Cancer Research. All rights reserved.